Zou et al., 2015
- An internal promoter underlies the difference in disease severity between N- and C-terminal truncation mutations of Titin.
eLIFE
4:e09406
Full text @ Elife
| Target | Reagent |
|---|---|
| ttn.2 | CRISPR1-ttn.2 |
| CRISPR2-ttn.2 | |
| CRISPR3-ttn.2 | |
| CRISPR4-ttn.2 | |
| CRISPR5-ttn.2 | |
| CRISPR6-ttn.2 | |
| CRISPR7-ttn.2 | |
| CRISPR8-ttn.2 | |
| CRISPR9-ttn.2 | |
| CRISPR10-ttn.2 | |
| CRISPR11-ttn.2 |